Ocular Toxoplasmosis
DR. PRABHAT DEVKOTA
MBBS(TU), MD(NAMS)
Layout
• Introduction
• Causative organism
• Epidemiology
• Risk factors
• Systemic syndrome
• Ocular Toxoplasmosis
• Signs and symptoms
• Management
Introduction
Causative organism
Toxoplasma gondii
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii
History
4
First observed in rodents by Nicolle and Manceaux
Named Toxoplasma gondii from Greek word toxon meaning arc
and gondii is name of North African desert rodent
Janku demonstrated parasitic cyst in retina of a child who died of
hydrocephalus, microphthalmia and coloboma in macular region
Toxoplasmosis was identified as most common cause of posterior
uveitis worldwide
1908
1960
1923
5
Genotypes
• 3 genotypes: Type I, II and III
Type I Type II Type III
• Very virulent
• Post natal acquired
infection
• Associated with strong pro-
inflammatory response and
severe tissue damage
• Least virulent
• Encyst in tissue under
immune response
• Responsible for chronic
infection
• Congenital infection and
encephalitis
• Less virulent
Lifecycle
8
Epidemiology In Nepal
• Toxoplasma infection in selected patients in Kathmandu, Nepal
• 272 patients with:
• Ocular diseases(uveitis, retinochoroiditis)
• Malignancy(including leukemia)
• Women with bad obstetric history(BOH) and
• Others( patients with fever, lymphadenitis and encephalitis)
Rai SK, Upadhyay MP, Shrestha HG. Toxoplasma infection in selected patients in Kathmandu, Nepal.
Nepal Medical College journal: NMCJ. 2003 Dec;5(2):89-91
9
Contd…
• Toxoplasma antibodies were detected by microlatex agglutination and
IgM ELISA techniques
• Overall, 50.7%(132) had Toxoplasma antibodies, out of which 5.7%(8)
had IgM antibodies
• Patient with malignancy had highest positive rate(68%)
• Women with BOH had highest Toxoplasma IgM positive rate(25%)
Rai SK, Upadhyay MP, Shrestha HG. Toxoplasma infection in selected patients in Kathmandu, Nepal.
Nepal Medical College journal: NMCJ. 2003 Dec;5(2):89-91
Patterns of Uveitis among Nepalese
Population Presenting at a Tertiary Referral
Eye Care Centre in Nepal
• Study period: 2012-2017
• Total patient attending BPKLCOS: 5,34,292
• Total patient diagnosed with uveitis: 4359 [0.82%]
• Patients diagnosed with toxoplasmosis : 272 [6.24%]
Kharel R, Khatri A, et al. Patterns of uveitis among Nepalese population presenting at a tertiary
referral eye care centre in Nepal. DOI: 10.15761/NFO.1000238
11
Modes Of Transmission
Incubation period:
10 to 23 days after ingesting contaminated meat
5 to 20 days after exposure to infected cats
Risk factors
• Exposure to environments where the infectious organism is
found, especially those frequented by felines.
• Increased risk of infection in males, if you own more than 3
kittens, and eating raw or undercooked meat (lamb, ground
beef, shell fish, game).
13
Pathogenesis
• Depends on a delicate balance between host immunity and parasite
virulence
Adaptive immune response is medicated by CD4+ T lymphocytes and
macrophages
synthesis of various proinflammatory cytokinesIL-12,IFN γ and TNF α
act synergistically to contain parasite replication
• Th 2 response counterbalances proinflammatory Th 1 pathway
Ocular Toxoplasmosis
Clinical Manifestation
15
Toxoplasmosis
Acquired
Immunocompetent Immunocompromised
Congenital Ocular
16
Immunocompetent Patients
• Generally asymptomatic
• 10-20% will develop cervical lymphadenopathy and or flu like illness
• Benign clinical course
• Early retinitis may occur in about 20%
• Symptoms usually resolve without treatment within weeks to months,
although some cases may take upto year
17
Immunocompromised Patients
• May be acquired or result from reactivation of pre-existing disease
• Often severe
• Neurologic disease is most common sign, particularly in reactivated
infection
• May develop encephalitis, chorioretinitis, myocarditis and
pneumonitis
• Can cause multiple abscesses in nervous tissue with symptoms of
mass lesion
18
Congenital Toxoplasmosis
• Results from acute primary infection acquired by mother
• 40% of primary maternal infection can cause congenital infection
• Transplacental transmission is highest during 3rd
trimester, but
severity is inversely proportional to gestational age
• Fetal death occurs in 10% of all congenital toxoplasmosis
• Neurological and visceral involvement may be subclinical
19
Congenital Toxoplasmosis
• Results from acute primary infection acquired by mother
• 40% of primary maternal infection can cause congenital infection
• Transplacental transmission is highest during 3rd
trimester, but
severity is inversely proportional to gestational age
• Fetal death occurs in 10% of all congenital toxoplasmosis
• Neurological and visceral involvement may be subclinical
Congenital Toxoplasmosis
21
Contd…
• Retinochoroiditis occur in over 75% leaving scars that are commonly a
later incidental finding
• Early infection: spontaneous abortion, still birth, severe congenital
disease
• Late infection: asymptomatic, normal appearing infant with latent
infection
Contd..
22
Retinochoroiditis Hydrocephalus or microcephaly Intracranial calcifications
Sabin’s tetrad
Cognitive impairment
23
Contd..
• Generalized disease
• Exanthematous rash
• Petechiae
• Ecchymosis
• Icterus
• Fever or hypothermia
• Anemia
• Lymphadenopathy
• Hepatosplenomegaly
• Pneumonitis
• Vomiting and diarrhea
24
Contd…
• Ocular sequalae
• 25% of these become blind in one or both eyes
• Retinochoroidal scars
• Cataracts
• Microphthalmia
• Phthisis bulbi
• Strabismus
• Nystagmus
• Optic atrophy
• Macular membrane
25
Postnatal Childhood Acquisition
• Accounts for 50% cases of childhood toxoplasmosis
• Ocular lesions are common but may not develop for years after initial
infection
26
Ocular Toxoplasmosis
• 20-60% of all posterior uveitis
• 80-90% congenital
• Classic lesion:
• Focal necrotizing retinochoroiditis with vitreous inflammation can be
accompanied by granulomatous anterior uveitis
• Retina: primary site of parasite multiplication
• Choroid and sclera: site of contiguous inflammation
27
Cont…
• Lesions in macular area:
• 76% macular involvement
• Established as result of entrapment of freely swimming organisms or parasite
containing macrophages in terminal capillaries of perifoveal retina
28
Symptoms
• Blurred vision
• Floaters
• Eye pain
• Redness
• Metamorphopsia
• Photophobia
29
Signs
• Anterior uveitis
• Elevated IOP - 20% cases
• May develop
• Mutton fat KPs
• Posterior synechiae
• Fibrin deposition
• Koeppe and Bussaca nodules
Prompt therapy to avoid complication like
pupillary seclusions, rubeosis iridis, secondary
glaucoma
30
Signs
• Vitritis severe
• Retino-choroiditis with vitritis
Headlight in fog appearance
Complication: PVD, Vitreous
Contraction, RD
31
Single fluffy white lesion
associated with pigmented
scar(satellite lesion adjacent to
old scar)
De novo foci: not associated
with old scar/multiple lesions
Inflammatory focus
32
Vascular Involvement
• Either in vicinity of active lesion or in distance retina
• Diffuse or segmental vasculitis
• Ag-Ab complex deposition in vessel wall
• Primarily involves vein
Complications: Retinal
hemorrhage, vascular
obstruction, shunting,
neovascularization
33
Contd…
Periarterial lipid exudate
Kyerieleis Arteriolitis
34
Subretinal Neovascularization
Retinal ischemia
associated with
severe retinal
vasculitis
Inflammatory
reactions
Neovascularization of retina
35
Optic Nerve Involvement
• Optic neuritis or papillitis associated with edema
• Direct extension of cerebral infection through sheath of optic nerve
• Patient with toxoplasma papillitis may present without evidence of
focus of retinitis
36
Atypical Toxoplasmosis
• Multifocal retinochoroiditis
• Low-grade or absent vitreal infiltration
• Absence of retinochoroidal scar
• Bilaterality
• Optic disc involvement
• Choroiditis without retinitis
37
Forms of atypical retinitis:
Punctate outer retinal toxoplasmosis
Neuroretinitis (aggressively involving ON)
Neuritis
Multiple pseudoretinitis
Punctate outer retinal toxoplamosis(PORT) Small, multifocal
gray white lesion
Minimal vitreous involvement and punctate infiltrates in outer
retina with serous RD
38
Neuroretinitis
• Active lesions localized to
juxtrapapillary region,
aggressively involving retina and
optic nerve
• Initially presents as severe
papillitis with disc hemorrhages,
venous engorgement and
overlying vitritis
Multiple pseudoretinitis
• Simultaneous presence of retinal lesions, which appears to be active
• However, close observation reveals just a single active lesion
accompanied by noncontiguous areas of retinal edema
• Once true active lesion heals, pseudo lesions completely disappear
without scarring
39
40
Healing
• Spontaneously 6-8weeks
• Associated with decrease in retinal edema and flattening of lesion
with evidence of scar formation surrounded by variable amounts
of pigment
41
42
New or Acute lesion
• Intensely white
• Focal lesion overlying
vitreous inflammatory haze
• Acute anterior uveitis
Healed lesion
• Border become more
defined
• Hyperpigmented after
several months
• Large scar will have
atrophic center
43
Recurrent Toxoplasmic Retinitis
• Retinochoroiditis scar may harbor
toxoplasmic cyst
• Immunological suppression recurrence
• Frequently appears as satellite or occurs
adjacent to previous scar
• Lesion tends to involve posterior pole
44
Toxoplasmosis
Immunocompetent Immunocompromised
Isolated often unilateral lesion Multifocal and bilateral
White fluffy focus of necrotizing retinitis
with associated retinal edema, retinal
vasculitis and vitritis
Less vitritis and lesions may simulate
appearance of viral retinitis such as ARN or
CMV retinitis
Secondary non granulomatous
inflammation of adjacent choroid and
sclera
45
Variants
• 1st
variant: Lesions larger than 1DD dense and elevated
• Largely destructive lesion with significant vitritis and AC reaction
• Prompt therapy is necessary
• 2nd
variant: Punctate lesions of inner retina
• Inflammation is mild
• No therapy necessary unless lesion is close to macula and vision threatening
• 3rd
variant: Punctate lesions in outer retina and mild vitritis
• Lesion slowly resolves spontaneously
46
Complications
Permanent
vision loss
• Macular inflammatory lesion and edema
• Optic nerve involvement
• Vascular occlusion
• Serous, rhegmatogenous and tractional RD
• Late secondary choroidal neovascularization
47
Complications
• Secondary glaucoma
• Cataract
• Vitreous hemorrhage
• Proliferative vitreoretinopathy
• Retinal detachment
• Macular dragging
• Epiretinal membrane
• Cystoid macular edema
• Macular hole
• Retinovascular occlusion
• Vascular shunts
• Choroidal neovascular
membrane
• Optic atrophy
• Phthis
48
Diagnosis
• Serological tests: IgG, IgM, Sabin-Feldman dye test
• Polymerase chain reaction (PCR) for intraocular fluid
• Diagnostic pars plana vitrectomy with or without choroidal biopsy
• Imaging modalities
• B-scan: to exclude RD if severe vitritis present
• OCT
• Fluorescein angiography
49
Serology
• IgG antibody
• Usually appears within 1-2 weeks of infection, peak within 1-2 months, fall at
variable rates and usually persist for life
• Titer doesn’t correlate with severity of illness
• Crosses placenta
• IgM antibody
• Determine acute phase of infection or in distant past
• Persist for month to more than year
• Do not cross placenta
• Presence of IgM in newborns confirm congenital infection
50
Ocular Fluid Antibody Assessment
• Goldman-Witmer coefficient
• Ratio of specific IgG in aqueous humor to that in serum as measured by ELISA
or radioimmunoassay
• GW ratio:
• <2 in immunocompetent patient- no active ocular toxoplasmosis
• Between 2 and 4- active ocular disease
• >4 is diagnostic of active ocular toxoplasmosis
51
Polymerase Chain Reaction
• Used to detect T.gondii DNA in body fluids and tissues
• Used to diagnose congenital, ocular, cerebral and disseminated
toxoplasmosis
• PCR performed on amniotic fluiddiagnosis of fetal T.gondii infection
52
Imaging
• OCT: hyperreflectivity of retinal layers with thickening of posterior
hyaloid
53
Differential Diagnosis
Infectious
• Cytomegalovirus
• Syphilis
• Herpes simplex
• Tuberculosis
• Toxocariasis
Non-infectious
• Retinal and choroidal coloboma
• Retinoblastoma
• Retinopathy of prematurity
• Retinal vascular membrane
• Serpiginous choroidopathy
54
Differential Diagnosis(Atypical Presentation)
• Acute posterior multifocal placoid pigment epitheliopathy
• Punctate inner choroidopathy
• Multifocal choroiditis
• Diffuse unilateral subacute neuroretinitis
55
Toxoplasma ARN of Viral
etiology
CMV Retinitis Chorioretinitis of
Tubercular etiology
Endogenous
Endohthalmitis
History Prior relapses +-/Acute
onset, Contact with
cats/dogs,
contaminated food
Generally, no prior
relapses e Acute
onset
Acute onset
Prior relapses
Insidious onset History of fever,
systemic
infections, acute
onset
Complaint Blur vision, pain or
watering
Blur vision /pain +/- Blur vision,
No pain
Blur vision, mild
pain/ redness+/
Blur vison, with
Pain and redness
Anterior
Segment
Granulomatous >
Nongranulomatous
KPs +/-, No hypopyon
Decrease in
corneal sensation
+/-, Diffuse
pigmented KPs, iris
atrophy+/
Diffuse
KPs+/-, No
hypopyon
Iris nodules/
granuloma +/-
granulomatous KPs,
Broad based
synechia
Hypopyon+/-,
Fibrinous
reaction+/-,
generally
nongranulomatou
s KPs +/
56
Toxoplasmosis ARN of viral
etiology
CMV retinitis Chorioretinitis of
tubercular
etiology
Endogenous
ophthalmitis
Posterior
segment
Moderate – severe
vitritis, generally single
retinitis lesion,
occasionally associated
chorio-retinal scars,
frequently associated
exudative vasculitis
Circumferential
progression,
arteriorlar
vasculitis,
Hemorrhages +/-,
No dense
scarring after
resolution
Larger lesions,
few
hemorrhages,
pizza pie
appearance, no
scarring after
resolution
choroidal or
outer retinal
lesions,
Occlusive
vasculitis +/
Generally larger
lesions arising
from choroid and
involving outer
retina first,
vasculitis
component is not
clear
OCT Thick ERM, Full thickness
retinal involvement,
choroidal elevation +/-
Full thickness
involvement, No
choroidal
elevation
Ellipsoid zone
disruption,
choroidal
involvement
Choroidal
elevation, outer
retinal
involvement first
57
Treatment
• Aim:
• To reduce risk of permanent visual loss
• To reduce recurrent retinochoroiditis
• To reduce severity and duration of acute symptoms
58
Indications
• Lesions threatening optic nerve or fovea
• Decreased visual acuity
• Lesions associated with moderate to severe vitreous inflammation
• Lesions greater than 1 disc diameter in size
• Persistence of disease for more than 1 month
• Presence of multiple active lesions
59
Indications
• Immunocompromise patient
• Congenital toxoplasmosis regardless of presence of ocular lesion
• Pregnant women with recently acquired disease
60
Medical Therapy
• Classic regimen
4-8 weeks
Folinic acid 5-10mg/day is added to prevent myelosuppression
Pyrimethamine
Loading dose 50-100mg/day
Maintenance dose 25-50mg/day
Sulfadiazine
Loading dose 2-4g
Maintenance dose 1g, 4times daily
61
Pyrimethamine
• Folic acid antagonist
• Mechanism of action
Inhibits dihydrofolate reductase enzyme
Preventing conversion of folic acid to folinic
• Adverse effects
• Leukopenia
• Thrombocytopenia
• Megaloblastic anemia
62
• Complete blood count- 2weekly
• Contraindicated in 1st
trimester of pregnancy
Sulfonamides
• Mechanism of action:
• Structural analogues and competitive antagonists of paraaminobenzoic acid
(PABA)
• Prevent normal utilization of PABA for synthesis of folic acid by parasites
• Adverse effects
• Crystalluria , hematuria, and renal damage
• Acute hemolytic anemia
• Agranulocytosis
• Hypersensitivity reactions
63
64
• Contraindications
• Glucose 6-phosphate dehydrogenase deficiency
• Third trimester of gestation
• Doses:
• Adults: 2gm loading dose followed by 1gm every 6hourly for 30-60days
• Children: 100mg/kg/day divided every 6hourly
• Newborns: 100mg/kg/day divided into 2 doses
65
Clindamycin
• Mechanism of action:
• Inhibits ribosomal protein synthesis
• Adverse effects :
• Pseudomembranous colitis
• Skin rashes
• Diarrhea
• Dose:
• Adult: 300mg every 6hours for 30-40 days
• Children: 16-20mg/kg/day divided every 6hourly
66
Intravitreal Therapy
• Advantages:
• Increased patient convenience
• Improved systemic side effect profile
• Greater drug availability
1mg of Clindamycin 0.4mg of Dexamethasone
67
Co-trimoxazole
• Mechanism of action:
• Trimethoprim prevents reduction from dihydrofolate to tetrahydrofolate
• Sulfamethoxazole inhibits incorporation of PABA in synthesis of folic acid
• Dose:
• 160/800mg(one tablet) every 12 hours for 30-40days
• Combination with prednisolone(1mg/kg)
70
Azithromycin
• Mechanism of action :
• Inhibits ribosomal protein synthesis
• Effective against encysted forms of parasite (bradyzoites) in vitro
• Dose:
• 500- 1000mg/ day for 3 weeks
• Reduce rate of recurrence of retinochoroiditis
71
Atovaquone
• Mechanism of action
• Interferes mitochondrial electrical transport chain
• Potent action against tachyzoites
• Theoretically attacks encysted bradyzoites but does not seem to
prevent recurrence in vivo
• Dose
• 750mg every 6hourly for 4-6weeks
• No serous adverse effects
72
Spiramycin
• Macrolide antibiotic and antiparasitic
• Protein synthesis inhibitor
• Reduces rate of tachyzoite transmission to fetus
• Drug of choice in pregnancy
• Dose:
• 500mg every 6hourly for 3 weeks, regimen may be repeated after 21 days
• Adults: 500-750 mg every 6hourly for 30-40 days
• Children: 100 mg/kg/day divided every 6hour
73
Treatment Updates
• Triple drug therapy
• Pyrimethamine + Sulfadiazine + Prednisolone
• Quadruple therapy
• Pyrimethamine + Sulfadiazine + Prednisolone + Clindamycin
74
Laser Photocoagulation
• For extramacular chronically exudative lesion in individuals
nonresponsive to or not tolerating systemic therapy
75
Pars Plana Vitrectomy
• For removal of persistent vitreous opacity or to relieve vitreoretinal
traction that may lead to retinal detachment
• Also removes antigenic proteins with inflammatory cells from vitreous
76
Course And Prognosis
• Recurrent disease
• Around 2/3rd
of patients develop reactivations later in life
• More common in congenital>postnatally acquired toxoplasmosis
• Occur especially in first year after previous episode
• Some patients, however, sustain long-lasting disease remission
Prevention
• Meat should be cooked to 600C for at least 15minutes or frozen to
temperature below -200C for at least 24hours to destroy cysts
• Any contact with cat feces should be avoided
• Hands should be washed after touching uncooked meat and after contact
with cats or soil that could be contaminated with cat feces
• Consumption of raw eggs and unpasteurized milk, particularly goat’s milk
should be avoided
77
78
Bibliography
• Uvea, American Academy of Ophthalmology, 2022-2023
• Kanski’s Clinical Ophthalmology, 9th
Edition
• Myron Yanoff and Jay S. Duker, Ophthalmology, 5th
Edition
• Uveitis, A Practical Guide to the Diagnosis and Treatment of
Intraocular Inflammation

Ocular Toxoplasmosis Dr. Prabhat Devkota.pptx

  • 1.
    Ocular Toxoplasmosis DR. PRABHATDEVKOTA MBBS(TU), MD(NAMS)
  • 2.
    Layout • Introduction • Causativeorganism • Epidemiology • Risk factors • Systemic syndrome • Ocular Toxoplasmosis • Signs and symptoms • Management
  • 3.
    Introduction Causative organism Toxoplasma gondii Toxoplasmosisis a parasitic disease caused by Toxoplasma gondii
  • 4.
    History 4 First observed inrodents by Nicolle and Manceaux Named Toxoplasma gondii from Greek word toxon meaning arc and gondii is name of North African desert rodent Janku demonstrated parasitic cyst in retina of a child who died of hydrocephalus, microphthalmia and coloboma in macular region Toxoplasmosis was identified as most common cause of posterior uveitis worldwide 1908 1960 1923
  • 5.
    5 Genotypes • 3 genotypes:Type I, II and III Type I Type II Type III • Very virulent • Post natal acquired infection • Associated with strong pro- inflammatory response and severe tissue damage • Least virulent • Encyst in tissue under immune response • Responsible for chronic infection • Congenital infection and encephalitis • Less virulent
  • 7.
  • 8.
    8 Epidemiology In Nepal •Toxoplasma infection in selected patients in Kathmandu, Nepal • 272 patients with: • Ocular diseases(uveitis, retinochoroiditis) • Malignancy(including leukemia) • Women with bad obstetric history(BOH) and • Others( patients with fever, lymphadenitis and encephalitis) Rai SK, Upadhyay MP, Shrestha HG. Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Medical College journal: NMCJ. 2003 Dec;5(2):89-91
  • 9.
    9 Contd… • Toxoplasma antibodieswere detected by microlatex agglutination and IgM ELISA techniques • Overall, 50.7%(132) had Toxoplasma antibodies, out of which 5.7%(8) had IgM antibodies • Patient with malignancy had highest positive rate(68%) • Women with BOH had highest Toxoplasma IgM positive rate(25%) Rai SK, Upadhyay MP, Shrestha HG. Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Medical College journal: NMCJ. 2003 Dec;5(2):89-91
  • 10.
    Patterns of Uveitisamong Nepalese Population Presenting at a Tertiary Referral Eye Care Centre in Nepal • Study period: 2012-2017 • Total patient attending BPKLCOS: 5,34,292 • Total patient diagnosed with uveitis: 4359 [0.82%] • Patients diagnosed with toxoplasmosis : 272 [6.24%] Kharel R, Khatri A, et al. Patterns of uveitis among Nepalese population presenting at a tertiary referral eye care centre in Nepal. DOI: 10.15761/NFO.1000238
  • 11.
    11 Modes Of Transmission Incubationperiod: 10 to 23 days after ingesting contaminated meat 5 to 20 days after exposure to infected cats
  • 12.
    Risk factors • Exposureto environments where the infectious organism is found, especially those frequented by felines. • Increased risk of infection in males, if you own more than 3 kittens, and eating raw or undercooked meat (lamb, ground beef, shell fish, game).
  • 13.
    13 Pathogenesis • Depends ona delicate balance between host immunity and parasite virulence Adaptive immune response is medicated by CD4+ T lymphocytes and macrophages synthesis of various proinflammatory cytokinesIL-12,IFN γ and TNF α act synergistically to contain parasite replication • Th 2 response counterbalances proinflammatory Th 1 pathway
  • 14.
  • 15.
  • 16.
    16 Immunocompetent Patients • Generallyasymptomatic • 10-20% will develop cervical lymphadenopathy and or flu like illness • Benign clinical course • Early retinitis may occur in about 20% • Symptoms usually resolve without treatment within weeks to months, although some cases may take upto year
  • 17.
    17 Immunocompromised Patients • Maybe acquired or result from reactivation of pre-existing disease • Often severe • Neurologic disease is most common sign, particularly in reactivated infection • May develop encephalitis, chorioretinitis, myocarditis and pneumonitis • Can cause multiple abscesses in nervous tissue with symptoms of mass lesion
  • 18.
    18 Congenital Toxoplasmosis • Resultsfrom acute primary infection acquired by mother • 40% of primary maternal infection can cause congenital infection • Transplacental transmission is highest during 3rd trimester, but severity is inversely proportional to gestational age • Fetal death occurs in 10% of all congenital toxoplasmosis • Neurological and visceral involvement may be subclinical
  • 19.
    19 Congenital Toxoplasmosis • Resultsfrom acute primary infection acquired by mother • 40% of primary maternal infection can cause congenital infection • Transplacental transmission is highest during 3rd trimester, but severity is inversely proportional to gestational age • Fetal death occurs in 10% of all congenital toxoplasmosis • Neurological and visceral involvement may be subclinical
  • 20.
  • 21.
    21 Contd… • Retinochoroiditis occurin over 75% leaving scars that are commonly a later incidental finding • Early infection: spontaneous abortion, still birth, severe congenital disease • Late infection: asymptomatic, normal appearing infant with latent infection
  • 22.
    Contd.. 22 Retinochoroiditis Hydrocephalus ormicrocephaly Intracranial calcifications Sabin’s tetrad Cognitive impairment
  • 23.
    23 Contd.. • Generalized disease •Exanthematous rash • Petechiae • Ecchymosis • Icterus • Fever or hypothermia • Anemia • Lymphadenopathy • Hepatosplenomegaly • Pneumonitis • Vomiting and diarrhea
  • 24.
    24 Contd… • Ocular sequalae •25% of these become blind in one or both eyes • Retinochoroidal scars • Cataracts • Microphthalmia • Phthisis bulbi • Strabismus • Nystagmus • Optic atrophy • Macular membrane
  • 25.
    25 Postnatal Childhood Acquisition •Accounts for 50% cases of childhood toxoplasmosis • Ocular lesions are common but may not develop for years after initial infection
  • 26.
    26 Ocular Toxoplasmosis • 20-60%of all posterior uveitis • 80-90% congenital • Classic lesion: • Focal necrotizing retinochoroiditis with vitreous inflammation can be accompanied by granulomatous anterior uveitis • Retina: primary site of parasite multiplication • Choroid and sclera: site of contiguous inflammation
  • 27.
    27 Cont… • Lesions inmacular area: • 76% macular involvement • Established as result of entrapment of freely swimming organisms or parasite containing macrophages in terminal capillaries of perifoveal retina
  • 28.
    28 Symptoms • Blurred vision •Floaters • Eye pain • Redness • Metamorphopsia • Photophobia
  • 29.
    29 Signs • Anterior uveitis •Elevated IOP - 20% cases • May develop • Mutton fat KPs • Posterior synechiae • Fibrin deposition • Koeppe and Bussaca nodules Prompt therapy to avoid complication like pupillary seclusions, rubeosis iridis, secondary glaucoma
  • 30.
    30 Signs • Vitritis severe •Retino-choroiditis with vitritis Headlight in fog appearance Complication: PVD, Vitreous Contraction, RD
  • 31.
    31 Single fluffy whitelesion associated with pigmented scar(satellite lesion adjacent to old scar) De novo foci: not associated with old scar/multiple lesions Inflammatory focus
  • 32.
    32 Vascular Involvement • Eitherin vicinity of active lesion or in distance retina • Diffuse or segmental vasculitis • Ag-Ab complex deposition in vessel wall • Primarily involves vein Complications: Retinal hemorrhage, vascular obstruction, shunting, neovascularization
  • 33.
  • 34.
    34 Subretinal Neovascularization Retinal ischemia associatedwith severe retinal vasculitis Inflammatory reactions Neovascularization of retina
  • 35.
    35 Optic Nerve Involvement •Optic neuritis or papillitis associated with edema • Direct extension of cerebral infection through sheath of optic nerve • Patient with toxoplasma papillitis may present without evidence of focus of retinitis
  • 36.
    36 Atypical Toxoplasmosis • Multifocalretinochoroiditis • Low-grade or absent vitreal infiltration • Absence of retinochoroidal scar • Bilaterality • Optic disc involvement • Choroiditis without retinitis
  • 37.
    37 Forms of atypicalretinitis: Punctate outer retinal toxoplasmosis Neuroretinitis (aggressively involving ON) Neuritis Multiple pseudoretinitis Punctate outer retinal toxoplamosis(PORT) Small, multifocal gray white lesion Minimal vitreous involvement and punctate infiltrates in outer retina with serous RD
  • 38.
    38 Neuroretinitis • Active lesionslocalized to juxtrapapillary region, aggressively involving retina and optic nerve • Initially presents as severe papillitis with disc hemorrhages, venous engorgement and overlying vitritis
  • 39.
    Multiple pseudoretinitis • Simultaneouspresence of retinal lesions, which appears to be active • However, close observation reveals just a single active lesion accompanied by noncontiguous areas of retinal edema • Once true active lesion heals, pseudo lesions completely disappear without scarring 39
  • 40.
    40 Healing • Spontaneously 6-8weeks •Associated with decrease in retinal edema and flattening of lesion with evidence of scar formation surrounded by variable amounts of pigment
  • 41.
  • 42.
    42 New or Acutelesion • Intensely white • Focal lesion overlying vitreous inflammatory haze • Acute anterior uveitis Healed lesion • Border become more defined • Hyperpigmented after several months • Large scar will have atrophic center
  • 43.
    43 Recurrent Toxoplasmic Retinitis •Retinochoroiditis scar may harbor toxoplasmic cyst • Immunological suppression recurrence • Frequently appears as satellite or occurs adjacent to previous scar • Lesion tends to involve posterior pole
  • 44.
    44 Toxoplasmosis Immunocompetent Immunocompromised Isolated oftenunilateral lesion Multifocal and bilateral White fluffy focus of necrotizing retinitis with associated retinal edema, retinal vasculitis and vitritis Less vitritis and lesions may simulate appearance of viral retinitis such as ARN or CMV retinitis Secondary non granulomatous inflammation of adjacent choroid and sclera
  • 45.
    45 Variants • 1st variant: Lesionslarger than 1DD dense and elevated • Largely destructive lesion with significant vitritis and AC reaction • Prompt therapy is necessary • 2nd variant: Punctate lesions of inner retina • Inflammation is mild • No therapy necessary unless lesion is close to macula and vision threatening • 3rd variant: Punctate lesions in outer retina and mild vitritis • Lesion slowly resolves spontaneously
  • 46.
    46 Complications Permanent vision loss • Macularinflammatory lesion and edema • Optic nerve involvement • Vascular occlusion • Serous, rhegmatogenous and tractional RD • Late secondary choroidal neovascularization
  • 47.
    47 Complications • Secondary glaucoma •Cataract • Vitreous hemorrhage • Proliferative vitreoretinopathy • Retinal detachment • Macular dragging • Epiretinal membrane • Cystoid macular edema • Macular hole • Retinovascular occlusion • Vascular shunts • Choroidal neovascular membrane • Optic atrophy • Phthis
  • 48.
    48 Diagnosis • Serological tests:IgG, IgM, Sabin-Feldman dye test • Polymerase chain reaction (PCR) for intraocular fluid • Diagnostic pars plana vitrectomy with or without choroidal biopsy • Imaging modalities • B-scan: to exclude RD if severe vitritis present • OCT • Fluorescein angiography
  • 49.
    49 Serology • IgG antibody •Usually appears within 1-2 weeks of infection, peak within 1-2 months, fall at variable rates and usually persist for life • Titer doesn’t correlate with severity of illness • Crosses placenta • IgM antibody • Determine acute phase of infection or in distant past • Persist for month to more than year • Do not cross placenta • Presence of IgM in newborns confirm congenital infection
  • 50.
    50 Ocular Fluid AntibodyAssessment • Goldman-Witmer coefficient • Ratio of specific IgG in aqueous humor to that in serum as measured by ELISA or radioimmunoassay • GW ratio: • <2 in immunocompetent patient- no active ocular toxoplasmosis • Between 2 and 4- active ocular disease • >4 is diagnostic of active ocular toxoplasmosis
  • 51.
    51 Polymerase Chain Reaction •Used to detect T.gondii DNA in body fluids and tissues • Used to diagnose congenital, ocular, cerebral and disseminated toxoplasmosis • PCR performed on amniotic fluiddiagnosis of fetal T.gondii infection
  • 52.
    52 Imaging • OCT: hyperreflectivityof retinal layers with thickening of posterior hyaloid
  • 53.
    53 Differential Diagnosis Infectious • Cytomegalovirus •Syphilis • Herpes simplex • Tuberculosis • Toxocariasis Non-infectious • Retinal and choroidal coloboma • Retinoblastoma • Retinopathy of prematurity • Retinal vascular membrane • Serpiginous choroidopathy
  • 54.
    54 Differential Diagnosis(Atypical Presentation) •Acute posterior multifocal placoid pigment epitheliopathy • Punctate inner choroidopathy • Multifocal choroiditis • Diffuse unilateral subacute neuroretinitis
  • 55.
    55 Toxoplasma ARN ofViral etiology CMV Retinitis Chorioretinitis of Tubercular etiology Endogenous Endohthalmitis History Prior relapses +-/Acute onset, Contact with cats/dogs, contaminated food Generally, no prior relapses e Acute onset Acute onset Prior relapses Insidious onset History of fever, systemic infections, acute onset Complaint Blur vision, pain or watering Blur vision /pain +/- Blur vision, No pain Blur vision, mild pain/ redness+/ Blur vison, with Pain and redness Anterior Segment Granulomatous > Nongranulomatous KPs +/-, No hypopyon Decrease in corneal sensation +/-, Diffuse pigmented KPs, iris atrophy+/ Diffuse KPs+/-, No hypopyon Iris nodules/ granuloma +/- granulomatous KPs, Broad based synechia Hypopyon+/-, Fibrinous reaction+/-, generally nongranulomatou s KPs +/
  • 56.
    56 Toxoplasmosis ARN ofviral etiology CMV retinitis Chorioretinitis of tubercular etiology Endogenous ophthalmitis Posterior segment Moderate – severe vitritis, generally single retinitis lesion, occasionally associated chorio-retinal scars, frequently associated exudative vasculitis Circumferential progression, arteriorlar vasculitis, Hemorrhages +/-, No dense scarring after resolution Larger lesions, few hemorrhages, pizza pie appearance, no scarring after resolution choroidal or outer retinal lesions, Occlusive vasculitis +/ Generally larger lesions arising from choroid and involving outer retina first, vasculitis component is not clear OCT Thick ERM, Full thickness retinal involvement, choroidal elevation +/- Full thickness involvement, No choroidal elevation Ellipsoid zone disruption, choroidal involvement Choroidal elevation, outer retinal involvement first
  • 57.
    57 Treatment • Aim: • Toreduce risk of permanent visual loss • To reduce recurrent retinochoroiditis • To reduce severity and duration of acute symptoms
  • 58.
    58 Indications • Lesions threateningoptic nerve or fovea • Decreased visual acuity • Lesions associated with moderate to severe vitreous inflammation • Lesions greater than 1 disc diameter in size • Persistence of disease for more than 1 month • Presence of multiple active lesions
  • 59.
    59 Indications • Immunocompromise patient •Congenital toxoplasmosis regardless of presence of ocular lesion • Pregnant women with recently acquired disease
  • 60.
    60 Medical Therapy • Classicregimen 4-8 weeks Folinic acid 5-10mg/day is added to prevent myelosuppression Pyrimethamine Loading dose 50-100mg/day Maintenance dose 25-50mg/day Sulfadiazine Loading dose 2-4g Maintenance dose 1g, 4times daily
  • 61.
    61 Pyrimethamine • Folic acidantagonist • Mechanism of action Inhibits dihydrofolate reductase enzyme Preventing conversion of folic acid to folinic • Adverse effects • Leukopenia • Thrombocytopenia • Megaloblastic anemia
  • 62.
    62 • Complete bloodcount- 2weekly • Contraindicated in 1st trimester of pregnancy
  • 63.
    Sulfonamides • Mechanism ofaction: • Structural analogues and competitive antagonists of paraaminobenzoic acid (PABA) • Prevent normal utilization of PABA for synthesis of folic acid by parasites • Adverse effects • Crystalluria , hematuria, and renal damage • Acute hemolytic anemia • Agranulocytosis • Hypersensitivity reactions 63
  • 64.
    64 • Contraindications • Glucose6-phosphate dehydrogenase deficiency • Third trimester of gestation • Doses: • Adults: 2gm loading dose followed by 1gm every 6hourly for 30-60days • Children: 100mg/kg/day divided every 6hourly • Newborns: 100mg/kg/day divided into 2 doses
  • 65.
    65 Clindamycin • Mechanism ofaction: • Inhibits ribosomal protein synthesis • Adverse effects : • Pseudomembranous colitis • Skin rashes • Diarrhea • Dose: • Adult: 300mg every 6hours for 30-40 days • Children: 16-20mg/kg/day divided every 6hourly
  • 66.
    66 Intravitreal Therapy • Advantages: •Increased patient convenience • Improved systemic side effect profile • Greater drug availability 1mg of Clindamycin 0.4mg of Dexamethasone
  • 67.
    67 Co-trimoxazole • Mechanism ofaction: • Trimethoprim prevents reduction from dihydrofolate to tetrahydrofolate • Sulfamethoxazole inhibits incorporation of PABA in synthesis of folic acid • Dose: • 160/800mg(one tablet) every 12 hours for 30-40days • Combination with prednisolone(1mg/kg)
  • 70.
    70 Azithromycin • Mechanism ofaction : • Inhibits ribosomal protein synthesis • Effective against encysted forms of parasite (bradyzoites) in vitro • Dose: • 500- 1000mg/ day for 3 weeks • Reduce rate of recurrence of retinochoroiditis
  • 71.
    71 Atovaquone • Mechanism ofaction • Interferes mitochondrial electrical transport chain • Potent action against tachyzoites • Theoretically attacks encysted bradyzoites but does not seem to prevent recurrence in vivo • Dose • 750mg every 6hourly for 4-6weeks • No serous adverse effects
  • 72.
    72 Spiramycin • Macrolide antibioticand antiparasitic • Protein synthesis inhibitor • Reduces rate of tachyzoite transmission to fetus • Drug of choice in pregnancy • Dose: • 500mg every 6hourly for 3 weeks, regimen may be repeated after 21 days • Adults: 500-750 mg every 6hourly for 30-40 days • Children: 100 mg/kg/day divided every 6hour
  • 73.
    73 Treatment Updates • Tripledrug therapy • Pyrimethamine + Sulfadiazine + Prednisolone • Quadruple therapy • Pyrimethamine + Sulfadiazine + Prednisolone + Clindamycin
  • 74.
    74 Laser Photocoagulation • Forextramacular chronically exudative lesion in individuals nonresponsive to or not tolerating systemic therapy
  • 75.
    75 Pars Plana Vitrectomy •For removal of persistent vitreous opacity or to relieve vitreoretinal traction that may lead to retinal detachment • Also removes antigenic proteins with inflammatory cells from vitreous
  • 76.
    76 Course And Prognosis •Recurrent disease • Around 2/3rd of patients develop reactivations later in life • More common in congenital>postnatally acquired toxoplasmosis • Occur especially in first year after previous episode • Some patients, however, sustain long-lasting disease remission
  • 77.
    Prevention • Meat shouldbe cooked to 600C for at least 15minutes or frozen to temperature below -200C for at least 24hours to destroy cysts • Any contact with cat feces should be avoided • Hands should be washed after touching uncooked meat and after contact with cats or soil that could be contaminated with cat feces • Consumption of raw eggs and unpasteurized milk, particularly goat’s milk should be avoided 77
  • 78.
    78 Bibliography • Uvea, AmericanAcademy of Ophthalmology, 2022-2023 • Kanski’s Clinical Ophthalmology, 9th Edition • Myron Yanoff and Jay S. Duker, Ophthalmology, 5th Edition • Uveitis, A Practical Guide to the Diagnosis and Treatment of Intraocular Inflammation

Editor's Notes

  • #4 Arc-to describe small crescentic shape of tachyzoites , desert rodent which is related to organism that T.gondii was originally found in By 1960
  • #5 Type II mainly found in USA Type I mostly found in Brazil where 80% of people are affected and 18% manifest retinochoroiditis
  • #7 sexual cycle takes place exclusively in feline intestine.- initially become infected by eating contaminated meat containing tissue cysts or by ingesting sporulated oocysts. In cat's intestine, tachyzoites invade epithelial cells n start to multiply by schizogony. During this process, gametocytes are formed n fertilized to produce oocysts. Ocyst r shed in env. It takes 1-5days to sporulate in env n become infective. Intermediate host rodents birds become infected by ingesting soil water or plant contaminated wid oocyst.oocyst transform into tachyzoites shortly after ingestion. These tachyzoites localize into neural n muscle tissue n develop into tissue cyst bradyzoites. Cats become infected by consuming intermediate host harbouring bradyzoites or ingestion of sporulated oocyst
  • #10 Bp Koirala lions center for ophthalmic studies , 2nd most common infectious disease 3 most commn infectious dz wre herpetic anterior uvieits ,13.95%, and tuberculosis , RA sarcoidosis
  • #11 Eating undercooked meat of animals harboring tissue cysts  . Consuming food or water contaminated with cat feces or by contaminated environmental samples (such as fecal-contaminated soil or changing the litter box of a pet cat)  . Blood transfusion or organ transplantation  . Transplacentally from mother to fetus In the human host, the parasites form tissue cysts, most commonly in skeletal muscle, myocardium, brain, and eyes; these cysts may remain throughout the life of the host
  • #13 cytokines, particularly ,, Th 2 response counterbalances proinflammatory Th 1 pathway Down-regulating protective immunity to T.gondii ..parasite virulence is also an imp determinant of pathogenesis d, 3 genogytpes, type 1 is highly virulent
  • #15 The clinical manifestation of toxoplasmosis depend upon the modality of infection: weather acquired, congenital or ocular Also depends if the host is immunecompetent or immunocompromised.
  • #16 Lymphanedopathy may be only presenting symptoms, however ocular toxoplasmosis may be seen even in immunocompetent hosts n is caused by reactivation of parasite after n initial self resolving infection of retina .. Severe symptoms: myositis, myocarditis, pneumonitis and neurologic signs including facial paralysis, severe reflex alterations, hemiplegia and coma
  • #17 Wen host is immunocompromised, reactivation of latent parasite or acute infectin is more systemi n severe
  • #18 Occurs wen mother becomes infected wid parasite during pregnancy n if is passed to fetus via placenta
  • #19 Occurs wen mother becomes infected wid parasite during pregnancy n if is passed to fetus via placenta
  • #22 <10% of infected child, retinal choroidal lesion r seen in 80% of infected child Classic presentationand
  • #24 Entire thickness of retina and choroid is destroyed in necrotizing inflammation so punched-out heavily pigmented scar remains Ocular lesions are usually associated with encephalitis and there is history of convulsions
  • #27 TThe acute lesion typically arises from the border of a chorioretinal scar These lesions often remain active for up to 16 weeks and then resolve,leaving a hyperpigmented scar
  • #28 unilateral
  • #29 Anterior uveitis (spill over granulomatous).. Due to hypersensitivity to T. antigen
  • #30 Vitreous involvmnt may occur as localized or diffuse exudate, inflammatory cells, pigmnts or hemorrhage…retinochoroiditis wid vitritis usually intensely yellowish white or grey focal lesions overying vitreos inflammatory haze->may give headlight in fog appearance..wen there is severe n prolongd vitreous involvement  vitreus contration post vitreous detachment or evn retinal detachment may occur
  • #31 De novo foci (usually seen in immunocompromised patients)
  • #32 But arterial involvement is not uncommon
  • #33 Presence of periarterial lipid exudates,appears as multiple segmental yellowh white lesion in beaded pattern. Etiology is nt knwn bt they alwz reflect severe intraocular inflammation. Toxo is mst frequently reported cause.other- syphilis , tb viral
  • #34 The neovascularization regresses with resolution of the inflammation
  • #36 Ocuur in immunocomprsmed pt , HIV pt with CD4 <100,pt on chronic immunosuppression or corticosteroids n elderly pt. they can hav mor sever presentation
  • #37 Acute lesions resolve leaving behind fine granular white scars but they frequently recur
  • #40 In immunocompetent…Inflammatory focus replaced by well defined border with central retinochoroidal atrophy n peripheral retinal pigmnt epithelial hyperplasia
  • #41 A healed Toxoplasma scar typically has well-defined borders with central retinochoroidal atrophy In atrophic central area, either choroidal vessels or bare sclera may be observed. Healing Toxoplasma .lesions may be complicated by proliferative vitreoretinopathy, retinal gliosis, vascular shunts, and choroidal neovascular membranes Traction bands are also frequent, and they usually link an old scar to the optic disc (Franceschetti's syndrome) or to a neighboring scar
  • #42 Focal lesion overlying vitreous inflammatory haze (head light in the fog) Large scar will have atrophic center (devoid of all choroidal retinal elements)
  • #43 satellite(single inflammatory focus or fluffy white retinitis or retinochoroiditis)
  • #45 There are three main morphological variants
  • #46 Vision loss 25%
  • #47 glaucoma -mechanical obstruction of TM with fibrin, inflammatory cells, or debris Cataracts - severe vitreous inflammation or use of local and systemic corticosteroids. PSC is typical Vitreous hemorrhage and tractional or rhegmatogenous retinal detachment - proliferative vitreoretinopathy and contraction ofvitreous bands. Proliferative vitreoretinopathy and tractional bands - macular dragging. epiretinal membranes - macular pucker and cystoid macular edema. Cystoid macular edema -chronic inflammation. macular cyst - macular hole. Retinal occlusion -retinal vein occlusion around or within active lesions venous occlusions are more common. Arteriovenous shunts in the retina and chorioretinal vascular anastomosis - complications of vascular obstruction . Disruption ofBruch's membrane - necrotizing retinochoroiditis - choroidal neovascular membranes, - adjacent to the retinal scar or at a distant location with feeder vessels originating from the scar. Optic nerve atrophy -primary involveof the optic nerve, peripapillary'lesions, or lesions localized in the papillomacular bundle. punctate outer retinal toxoplasmosis - frequent optic nerve atrophy..
  • #48 Diagnosis of ocular toxo is mst oftn made by clinical findings,serology can b supportive in making diagnosis. PCR analysis can aid in diagnosis particularly in immunosupresd pt where serology may b less sensitive. PPV-if diagnosis remain uncertain.. to obtain tissue for analysis.. Oct-aid in further characterizing retinal lesions n accompanying findings vascular leakage, oclusin macular edema or choroidal neovascularization.. To look for progressin.
  • #49 Using indirect fluorescence ab and ELISA to detect specific anti T.gondii ab
  • #50 Intraocular production of specific anti-Toxoplasma antibodies may be computed using this coefficient
  • #51 PCR has allowed detection of T.gondii DNA in brain tissue, cerebrospinal fluid, vitreous and aqueous fluid, bronchoalveolar lavage fluid, urine, amniotic and peripheral blood Its principle is based on the use of DNA polymerase which is an in vitro replication of specific DNA sequences.. he DNA polymerase is the key enzyme that links individual nucleotides together to form the PCR product.
  • #52 Red arrows: indicate disorganization of inner/middle highly refective layers adjacent active lesion, yellow: disorganization of retinal layer(smudge effect), green : hyperreflective signals in overlying vitreos
  • #53 Toxocariasis-chronic endopth, post pole or peripheral granuloma without inflammation
  • #57 Ocular toxo Is progressive n recurrent dz,..In immunocompetent pt,dz can have self limiting course, in immunocompromizd dz is ofn severe n progressive. It has no cure as no drug are found to be effective against tissue cyst. Bt parasite activity n multiplication can be reduced n decrease size of retinochoroidal scar
  • #58 2 line drop in VA before infection. d/t vitritis
  • #59 those with AIDS with neoplastic disease or undergoing IMT
  • #60 Myelosuppresion which may reslt from pyrimethamine therapy
  • #61 folinic acid which is essential in both DNA and RNA synthesis. Dose related bone marrow suppression
  • #62 Stopped if platelet count falls below 100,000/ml or leukocyte count falls below 4000 cells, folinic acid retard thrombocytopenia, leukopenia and folate deficiency …teratogenic effect. Used in caution in hepatic or renal failure
  • #63 Sulfadiazine, sulfamerazine and sulfamethazine
  • #64 G6PD- cause hemolysis Newborns given daily for 1st year of life
  • #65 Clindamycin maybe added to regimen or substituted for sulfadiazine in case of sulfa allergy. Clindamycin either alone or in combination wid other drugs has been efectiv in managing acute lesion
  • #66 Advantages of intravitreal treatment include increased pt convenience,improved systemic side effect profile, greater drug availability and fewer follow-up visits and hematological evaluations
  • #67 Other treatment regimn include..prednisolone is started from 3rd day after anti-toxoplasmosis therapy
  • #72 Spiramycin- drug of choice during pregnancy. It achieves a high concentration in the placenta and has no reported teratogenic effects. Spiramycin may reduce the incidence of congenital transmission
  • #73 Prednisolone is started 24-48hrs after initiation of anti toxo therapy..Greater reduction in size of retinal lesion. When antimicrobial therapy is given it kills parasite leading to release of toxins leading to inflammation, so prednisolone 1mg/kg is given ,reduces risk of complications like CME persistent vitritis and perivascular inflammation
  • #76 Prognosis depends on immune status n age of pt, size n location of lesion